Global Finasteride Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Finasteride is a prescription drug in tablet form.
LPI (LP Information)' newest research report, the “Finasteride Industry Forecast” looks at past sales and reviews total world Finasteride sales in 2022, providing a comprehensive analysis by region and market sector of projected Finasteride sales for 2023 through 2029. With Finasteride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride industry.
This Insight Report provides a comprehensive analysis of the global Finasteride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Finasteride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride.
The global Finasteride market size is projected to grow from US$ 115.8 million in 2022 to US$ 153.3 million in 2029; it is expected to grow at a CAGR of 153.3 from 2023 to 2029.
United States market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Finasteride players cover Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Finasteride market?
What factors are driving Finasteride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Finasteride market opportunities vary by end market size?
How does Finasteride break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Finasteride is a prescription drug in tablet form.
LPI (LP Information)' newest research report, the “Finasteride Industry Forecast” looks at past sales and reviews total world Finasteride sales in 2022, providing a comprehensive analysis by region and market sector of projected Finasteride sales for 2023 through 2029. With Finasteride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride industry.
This Insight Report provides a comprehensive analysis of the global Finasteride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Finasteride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride.
The global Finasteride market size is projected to grow from US$ 115.8 million in 2022 to US$ 153.3 million in 2029; it is expected to grow at a CAGR of 153.3 from 2023 to 2029.
United States market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Finasteride is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Finasteride players cover Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 1mg Tablet
- 5mg Tablet
- Medical Uses
- Application 2
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Actavis
- Sandoz
- Teva Pharmaceuticals
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Henan Topfond
- Zhejiang CONBA Pharmaceutical
- Shandong Renhetang Pharmaceutical
- Guangdong Eashu Pharmacetical
What is the 10-year outlook for the global Finasteride market?
What factors are driving Finasteride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Finasteride market opportunities vary by end market size?
How does Finasteride break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Finasteride Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Finasteride by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Finasteride by Country/Region, 2018, 2022 & 2029
2.2 Finasteride Segment by Type
2.2.1 1mg Tablet
2.2.2 5mg Tablet
2.3 Finasteride Sales by Type
2.3.1 Global Finasteride Sales Market Share by Type (2018-2023)
2.3.2 Global Finasteride Revenue and Market Share by Type (2018-2023)
2.3.3 Global Finasteride Sale Price by Type (2018-2023)
2.4 Finasteride Segment by Application
2.4.1 Medical Uses
2.4.2 Application
2.5 Finasteride Sales by Application
2.5.1 Global Finasteride Sale Market Share by Application (2018-2023)
2.5.2 Global Finasteride Revenue and Market Share by Application (2018-2023)
2.5.3 Global Finasteride Sale Price by Application (2018-2023)
3 GLOBAL FINASTERIDE BY COMPANY
3.1 Global Finasteride Breakdown Data by Company
3.1.1 Global Finasteride Annual Sales by Company (2018-2023)
3.1.2 Global Finasteride Sales Market Share by Company (2018-2023)
3.2 Global Finasteride Annual Revenue by Company (2018-2023)
3.2.1 Global Finasteride Revenue by Company (2018-2023)
3.2.2 Global Finasteride Revenue Market Share by Company (2018-2023)
3.3 Global Finasteride Sale Price by Company
3.4 Key Manufacturers Finasteride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride Product Location Distribution
3.4.2 Players Finasteride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FINASTERIDE BY GEOGRAPHIC REGION
4.1 World Historic Finasteride Market Size by Geographic Region (2018-2023)
4.1.1 Global Finasteride Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Finasteride Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Finasteride Market Size by Country/Region (2018-2023)
4.2.1 Global Finasteride Annual Sales by Country/Region (2018-2023)
4.2.2 Global Finasteride Annual Revenue by Country/Region (2018-2023)
4.3 Americas Finasteride Sales Growth
4.4 APAC Finasteride Sales Growth
4.5 Europe Finasteride Sales Growth
4.6 Middle East & Africa Finasteride Sales Growth
5 AMERICAS
5.1 Americas Finasteride Sales by Country
5.1.1 Americas Finasteride Sales by Country (2018-2023)
5.1.2 Americas Finasteride Revenue by Country (2018-2023)
5.2 Americas Finasteride Sales by Type
5.3 Americas Finasteride Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride Sales by Region
6.1.1 APAC Finasteride Sales by Region (2018-2023)
6.1.2 APAC Finasteride Revenue by Region (2018-2023)
6.2 APAC Finasteride Sales by Type
6.3 APAC Finasteride Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Finasteride by Country
7.1.1 Europe Finasteride Sales by Country (2018-2023)
7.1.2 Europe Finasteride Revenue by Country (2018-2023)
7.2 Europe Finasteride Sales by Type
7.3 Europe Finasteride Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Finasteride by Country
8.1.1 Middle East & Africa Finasteride Sales by Country (2018-2023)
8.1.2 Middle East & Africa Finasteride Revenue by Country (2018-2023)
8.2 Middle East & Africa Finasteride Sales by Type
8.3 Middle East & Africa Finasteride Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride
10.3 Manufacturing Process Analysis of Finasteride
10.4 Industry Chain Structure of Finasteride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride Distributors
11.3 Finasteride Customer
12 WORLD FORECAST REVIEW FOR FINASTERIDE BY GEOGRAPHIC REGION
12.1 Global Finasteride Market Size Forecast by Region
12.1.1 Global Finasteride Forecast by Region (2024-2029)
12.1.2 Global Finasteride Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Finasteride Forecast by Type
12.7 Global Finasteride Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Finasteride Product Portfolios and Specifications
13.1.3 Merck Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Actavis
13.2.1 Actavis Company Information
13.2.2 Actavis Finasteride Product Portfolios and Specifications
13.2.3 Actavis Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Actavis Main Business Overview
13.2.5 Actavis Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Finasteride Product Portfolios and Specifications
13.3.3 Sandoz Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Finasteride Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Finasteride Product Portfolios and Specifications
13.5.3 Cipla Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 RelonChem
13.6.1 RelonChem Company Information
13.6.2 RelonChem Finasteride Product Portfolios and Specifications
13.6.3 RelonChem Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 RelonChem Main Business Overview
13.6.5 RelonChem Latest Developments
13.7 Dr. Reddy
13.7.1 Dr. Reddy Company Information
13.7.2 Dr. Reddy Finasteride Product Portfolios and Specifications
13.7.3 Dr. Reddy Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Reddy Main Business Overview
13.7.5 Dr. Reddy Latest Developments
13.8 Accord Pharmaceuticals
13.8.1 Accord Pharmaceuticals Company Information
13.8.2 Accord Pharmaceuticals Finasteride Product Portfolios and Specifications
13.8.3 Accord Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Accord Pharmaceuticals Main Business Overview
13.8.5 Accord Pharmaceuticals Latest Developments
13.9 Henan Topfond
13.9.1 Henan Topfond Company Information
13.9.2 Henan Topfond Finasteride Product Portfolios and Specifications
13.9.3 Henan Topfond Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Henan Topfond Main Business Overview
13.9.5 Henan Topfond Latest Developments
13.10 Zhejiang CONBA Pharmaceutical
13.10.1 Zhejiang CONBA Pharmaceutical Company Information
13.10.2 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolios and Specifications
13.10.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zhejiang CONBA Pharmaceutical Main Business Overview
13.10.5 Zhejiang CONBA Pharmaceutical Latest Developments
13.11 Shandong Renhetang Pharmaceutical
13.11.1 Shandong Renhetang Pharmaceutical Company Information
13.11.2 Shandong Renhetang Pharmaceutical Finasteride Product Portfolios and Specifications
13.11.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shandong Renhetang Pharmaceutical Main Business Overview
13.11.5 Shandong Renhetang Pharmaceutical Latest Developments
13.12 Guangdong Eashu Pharmacetical
13.12.1 Guangdong Eashu Pharmacetical Company Information
13.12.2 Guangdong Eashu Pharmacetical Finasteride Product Portfolios and Specifications
13.12.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangdong Eashu Pharmacetical Main Business Overview
13.12.5 Guangdong Eashu Pharmacetical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Finasteride Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Finasteride by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Finasteride by Country/Region, 2018, 2022 & 2029
2.2 Finasteride Segment by Type
2.2.1 1mg Tablet
2.2.2 5mg Tablet
2.3 Finasteride Sales by Type
2.3.1 Global Finasteride Sales Market Share by Type (2018-2023)
2.3.2 Global Finasteride Revenue and Market Share by Type (2018-2023)
2.3.3 Global Finasteride Sale Price by Type (2018-2023)
2.4 Finasteride Segment by Application
2.4.1 Medical Uses
2.4.2 Application
2.5 Finasteride Sales by Application
2.5.1 Global Finasteride Sale Market Share by Application (2018-2023)
2.5.2 Global Finasteride Revenue and Market Share by Application (2018-2023)
2.5.3 Global Finasteride Sale Price by Application (2018-2023)
3 GLOBAL FINASTERIDE BY COMPANY
3.1 Global Finasteride Breakdown Data by Company
3.1.1 Global Finasteride Annual Sales by Company (2018-2023)
3.1.2 Global Finasteride Sales Market Share by Company (2018-2023)
3.2 Global Finasteride Annual Revenue by Company (2018-2023)
3.2.1 Global Finasteride Revenue by Company (2018-2023)
3.2.2 Global Finasteride Revenue Market Share by Company (2018-2023)
3.3 Global Finasteride Sale Price by Company
3.4 Key Manufacturers Finasteride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride Product Location Distribution
3.4.2 Players Finasteride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FINASTERIDE BY GEOGRAPHIC REGION
4.1 World Historic Finasteride Market Size by Geographic Region (2018-2023)
4.1.1 Global Finasteride Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Finasteride Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Finasteride Market Size by Country/Region (2018-2023)
4.2.1 Global Finasteride Annual Sales by Country/Region (2018-2023)
4.2.2 Global Finasteride Annual Revenue by Country/Region (2018-2023)
4.3 Americas Finasteride Sales Growth
4.4 APAC Finasteride Sales Growth
4.5 Europe Finasteride Sales Growth
4.6 Middle East & Africa Finasteride Sales Growth
5 AMERICAS
5.1 Americas Finasteride Sales by Country
5.1.1 Americas Finasteride Sales by Country (2018-2023)
5.1.2 Americas Finasteride Revenue by Country (2018-2023)
5.2 Americas Finasteride Sales by Type
5.3 Americas Finasteride Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride Sales by Region
6.1.1 APAC Finasteride Sales by Region (2018-2023)
6.1.2 APAC Finasteride Revenue by Region (2018-2023)
6.2 APAC Finasteride Sales by Type
6.3 APAC Finasteride Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Finasteride by Country
7.1.1 Europe Finasteride Sales by Country (2018-2023)
7.1.2 Europe Finasteride Revenue by Country (2018-2023)
7.2 Europe Finasteride Sales by Type
7.3 Europe Finasteride Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Finasteride by Country
8.1.1 Middle East & Africa Finasteride Sales by Country (2018-2023)
8.1.2 Middle East & Africa Finasteride Revenue by Country (2018-2023)
8.2 Middle East & Africa Finasteride Sales by Type
8.3 Middle East & Africa Finasteride Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride
10.3 Manufacturing Process Analysis of Finasteride
10.4 Industry Chain Structure of Finasteride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride Distributors
11.3 Finasteride Customer
12 WORLD FORECAST REVIEW FOR FINASTERIDE BY GEOGRAPHIC REGION
12.1 Global Finasteride Market Size Forecast by Region
12.1.1 Global Finasteride Forecast by Region (2024-2029)
12.1.2 Global Finasteride Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Finasteride Forecast by Type
12.7 Global Finasteride Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Finasteride Product Portfolios and Specifications
13.1.3 Merck Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Actavis
13.2.1 Actavis Company Information
13.2.2 Actavis Finasteride Product Portfolios and Specifications
13.2.3 Actavis Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Actavis Main Business Overview
13.2.5 Actavis Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Finasteride Product Portfolios and Specifications
13.3.3 Sandoz Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Finasteride Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Finasteride Product Portfolios and Specifications
13.5.3 Cipla Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 RelonChem
13.6.1 RelonChem Company Information
13.6.2 RelonChem Finasteride Product Portfolios and Specifications
13.6.3 RelonChem Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 RelonChem Main Business Overview
13.6.5 RelonChem Latest Developments
13.7 Dr. Reddy
13.7.1 Dr. Reddy Company Information
13.7.2 Dr. Reddy Finasteride Product Portfolios and Specifications
13.7.3 Dr. Reddy Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Reddy Main Business Overview
13.7.5 Dr. Reddy Latest Developments
13.8 Accord Pharmaceuticals
13.8.1 Accord Pharmaceuticals Company Information
13.8.2 Accord Pharmaceuticals Finasteride Product Portfolios and Specifications
13.8.3 Accord Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Accord Pharmaceuticals Main Business Overview
13.8.5 Accord Pharmaceuticals Latest Developments
13.9 Henan Topfond
13.9.1 Henan Topfond Company Information
13.9.2 Henan Topfond Finasteride Product Portfolios and Specifications
13.9.3 Henan Topfond Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Henan Topfond Main Business Overview
13.9.5 Henan Topfond Latest Developments
13.10 Zhejiang CONBA Pharmaceutical
13.10.1 Zhejiang CONBA Pharmaceutical Company Information
13.10.2 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolios and Specifications
13.10.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zhejiang CONBA Pharmaceutical Main Business Overview
13.10.5 Zhejiang CONBA Pharmaceutical Latest Developments
13.11 Shandong Renhetang Pharmaceutical
13.11.1 Shandong Renhetang Pharmaceutical Company Information
13.11.2 Shandong Renhetang Pharmaceutical Finasteride Product Portfolios and Specifications
13.11.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shandong Renhetang Pharmaceutical Main Business Overview
13.11.5 Shandong Renhetang Pharmaceutical Latest Developments
13.12 Guangdong Eashu Pharmacetical
13.12.1 Guangdong Eashu Pharmacetical Company Information
13.12.2 Guangdong Eashu Pharmacetical Finasteride Product Portfolios and Specifications
13.12.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangdong Eashu Pharmacetical Main Business Overview
13.12.5 Guangdong Eashu Pharmacetical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Finasteride Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Finasteride Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1mg Tablet
Table 4. Major Players of 5mg Tablet
Table 5. Global Finasteride Sales by Type (2018-2023) & (MT)
Table 6. Global Finasteride Sales Market Share by Type (2018-2023)
Table 7. Global Finasteride Revenue by Type (2018-2023) & ($ million)
Table 8. Global Finasteride Revenue Market Share by Type (2018-2023)
Table 9. Global Finasteride Sale Price by Type (2018-2023) & (USD/Kg)
Table 10. Global Finasteride Sales by Application (2018-2023) & (MT)
Table 11. Global Finasteride Sales Market Share by Application (2018-2023)
Table 12. Global Finasteride Revenue by Application (2018-2023)
Table 13. Global Finasteride Revenue Market Share by Application (2018-2023)
Table 14. Global Finasteride Sale Price by Application (2018-2023) & (USD/Kg)
Table 15. Global Finasteride Sales by Company (2018-2023) & (MT)
Table 16. Global Finasteride Sales Market Share by Company (2018-2023)
Table 17. Global Finasteride Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Finasteride Revenue Market Share by Company (2018-2023)
Table 19. Global Finasteride Sale Price by Company (2018-2023) & (USD/Kg)
Table 20. Key Manufacturers Finasteride Producing Area Distribution and Sales Area
Table 21. Players Finasteride Products Offered
Table 22. Finasteride Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Finasteride Sales by Geographic Region (2018-2023) & (MT)
Table 26. Global Finasteride Sales Market Share Geographic Region (2018-2023)
Table 27. Global Finasteride Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Finasteride Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Finasteride Sales by Country/Region (2018-2023) & (MT)
Table 30. Global Finasteride Sales Market Share by Country/Region (2018-2023)
Table 31. Global Finasteride Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Finasteride Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Finasteride Sales by Country (2018-2023) & (MT)
Table 34. Americas Finasteride Sales Market Share by Country (2018-2023)
Table 35. Americas Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Finasteride Revenue Market Share by Country (2018-2023)
Table 37. Americas Finasteride Sales by Type (2018-2023) & (MT)
Table 38. Americas Finasteride Sales by Application (2018-2023) & (MT)
Table 39. APAC Finasteride Sales by Region (2018-2023) & (MT)
Table 40. APAC Finasteride Sales Market Share by Region (2018-2023)
Table 41. APAC Finasteride Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Finasteride Revenue Market Share by Region (2018-2023)
Table 43. APAC Finasteride Sales by Type (2018-2023) & (MT)
Table 44. APAC Finasteride Sales by Application (2018-2023) & (MT)
Table 45. Europe Finasteride Sales by Country (2018-2023) & (MT)
Table 46. Europe Finasteride Sales Market Share by Country (2018-2023)
Table 47. Europe Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Finasteride Revenue Market Share by Country (2018-2023)
Table 49. Europe Finasteride Sales by Type (2018-2023) & (MT)
Table 50. Europe Finasteride Sales by Application (2018-2023) & (MT)
Table 51. Middle East & Africa Finasteride Sales by Country (2018-2023) & (MT)
Table 52. Middle East & Africa Finasteride Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Finasteride Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Finasteride Sales by Type (2018-2023) & (MT)
Table 56. Middle East & Africa Finasteride Sales by Application (2018-2023) & (MT)
Table 57. Key Market Drivers & Growth Opportunities of Finasteride
Table 58. Key Market Challenges & Risks of Finasteride
Table 59. Key Industry Trends of Finasteride
Table 60. Finasteride Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Finasteride Distributors List
Table 63. Finasteride Customer List
Table 64. Global Finasteride Sales Forecast by Region (2024-2029) & (MT)
Table 65. Global Finasteride Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 67. Americas Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Finasteride Sales Forecast by Region (2024-2029) & (MT)
Table 69. APAC Finasteride Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 71. Europe Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 73. Middle East & Africa Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Finasteride Sales Forecast by Type (2024-2029) & (MT)
Table 75. Global Finasteride Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Finasteride Sales Forecast by Application (2024-2029) & (MT)
Table 77. Global Finasteride Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Finasteride Product Portfolios and Specifications
Table 80. Merck Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Actavis Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 84. Actavis Finasteride Product Portfolios and Specifications
Table 85. Actavis Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 86. Actavis Main Business
Table 87. Actavis Latest Developments
Table 88. Sandoz Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 89. Sandoz Finasteride Product Portfolios and Specifications
Table 90. Sandoz Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 91. Sandoz Main Business
Table 92. Sandoz Latest Developments
Table 93. Teva Pharmaceuticals Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceuticals Finasteride Product Portfolios and Specifications
Table 95. Teva Pharmaceuticals Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 96. Teva Pharmaceuticals Main Business
Table 97. Teva Pharmaceuticals Latest Developments
Table 98. Cipla Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Finasteride Product Portfolios and Specifications
Table 100. Cipla Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 101. Cipla Main Business
Table 102. Cipla Latest Developments
Table 103. RelonChem Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 104. RelonChem Finasteride Product Portfolios and Specifications
Table 105. RelonChem Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 106. RelonChem Main Business
Table 107. RelonChem Latest Developments
Table 108. Dr. Reddy Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 109. Dr. Reddy Finasteride Product Portfolios and Specifications
Table 110. Dr. Reddy Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 111. Dr. Reddy Main Business
Table 112. Dr. Reddy Latest Developments
Table 113. Accord Pharmaceuticals Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 114. Accord Pharmaceuticals Finasteride Product Portfolios and Specifications
Table 115. Accord Pharmaceuticals Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 116. Accord Pharmaceuticals Main Business
Table 117. Accord Pharmaceuticals Latest Developments
Table 118. Henan Topfond Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 119. Henan Topfond Finasteride Product Portfolios and Specifications
Table 120. Henan Topfond Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 121. Henan Topfond Main Business
Table 122. Henan Topfond Latest Developments
Table 123. Zhejiang CONBA Pharmaceutical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang CONBA Pharmaceutical Finasteride Product Portfolios and Specifications
Table 125. Zhejiang CONBA Pharmaceutical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 126. Zhejiang CONBA Pharmaceutical Main Business
Table 127. Zhejiang CONBA Pharmaceutical Latest Developments
Table 128. Shandong Renhetang Pharmaceutical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Renhetang Pharmaceutical Finasteride Product Portfolios and Specifications
Table 130. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 131. Shandong Renhetang Pharmaceutical Main Business
Table 132. Shandong Renhetang Pharmaceutical Latest Developments
Table 133. Guangdong Eashu Pharmacetical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 134. Guangdong Eashu Pharmacetical Finasteride Product Portfolios and Specifications
Table 135. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 136. Guangdong Eashu Pharmacetical Main Business
Table 137. Guangdong Eashu Pharmacetical Latest Developments
Table 1. Finasteride Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Finasteride Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1mg Tablet
Table 4. Major Players of 5mg Tablet
Table 5. Global Finasteride Sales by Type (2018-2023) & (MT)
Table 6. Global Finasteride Sales Market Share by Type (2018-2023)
Table 7. Global Finasteride Revenue by Type (2018-2023) & ($ million)
Table 8. Global Finasteride Revenue Market Share by Type (2018-2023)
Table 9. Global Finasteride Sale Price by Type (2018-2023) & (USD/Kg)
Table 10. Global Finasteride Sales by Application (2018-2023) & (MT)
Table 11. Global Finasteride Sales Market Share by Application (2018-2023)
Table 12. Global Finasteride Revenue by Application (2018-2023)
Table 13. Global Finasteride Revenue Market Share by Application (2018-2023)
Table 14. Global Finasteride Sale Price by Application (2018-2023) & (USD/Kg)
Table 15. Global Finasteride Sales by Company (2018-2023) & (MT)
Table 16. Global Finasteride Sales Market Share by Company (2018-2023)
Table 17. Global Finasteride Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Finasteride Revenue Market Share by Company (2018-2023)
Table 19. Global Finasteride Sale Price by Company (2018-2023) & (USD/Kg)
Table 20. Key Manufacturers Finasteride Producing Area Distribution and Sales Area
Table 21. Players Finasteride Products Offered
Table 22. Finasteride Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Finasteride Sales by Geographic Region (2018-2023) & (MT)
Table 26. Global Finasteride Sales Market Share Geographic Region (2018-2023)
Table 27. Global Finasteride Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Finasteride Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Finasteride Sales by Country/Region (2018-2023) & (MT)
Table 30. Global Finasteride Sales Market Share by Country/Region (2018-2023)
Table 31. Global Finasteride Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Finasteride Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Finasteride Sales by Country (2018-2023) & (MT)
Table 34. Americas Finasteride Sales Market Share by Country (2018-2023)
Table 35. Americas Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Finasteride Revenue Market Share by Country (2018-2023)
Table 37. Americas Finasteride Sales by Type (2018-2023) & (MT)
Table 38. Americas Finasteride Sales by Application (2018-2023) & (MT)
Table 39. APAC Finasteride Sales by Region (2018-2023) & (MT)
Table 40. APAC Finasteride Sales Market Share by Region (2018-2023)
Table 41. APAC Finasteride Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Finasteride Revenue Market Share by Region (2018-2023)
Table 43. APAC Finasteride Sales by Type (2018-2023) & (MT)
Table 44. APAC Finasteride Sales by Application (2018-2023) & (MT)
Table 45. Europe Finasteride Sales by Country (2018-2023) & (MT)
Table 46. Europe Finasteride Sales Market Share by Country (2018-2023)
Table 47. Europe Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Finasteride Revenue Market Share by Country (2018-2023)
Table 49. Europe Finasteride Sales by Type (2018-2023) & (MT)
Table 50. Europe Finasteride Sales by Application (2018-2023) & (MT)
Table 51. Middle East & Africa Finasteride Sales by Country (2018-2023) & (MT)
Table 52. Middle East & Africa Finasteride Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Finasteride Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Finasteride Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Finasteride Sales by Type (2018-2023) & (MT)
Table 56. Middle East & Africa Finasteride Sales by Application (2018-2023) & (MT)
Table 57. Key Market Drivers & Growth Opportunities of Finasteride
Table 58. Key Market Challenges & Risks of Finasteride
Table 59. Key Industry Trends of Finasteride
Table 60. Finasteride Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Finasteride Distributors List
Table 63. Finasteride Customer List
Table 64. Global Finasteride Sales Forecast by Region (2024-2029) & (MT)
Table 65. Global Finasteride Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 67. Americas Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Finasteride Sales Forecast by Region (2024-2029) & (MT)
Table 69. APAC Finasteride Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 71. Europe Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Finasteride Sales Forecast by Country (2024-2029) & (MT)
Table 73. Middle East & Africa Finasteride Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Finasteride Sales Forecast by Type (2024-2029) & (MT)
Table 75. Global Finasteride Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Finasteride Sales Forecast by Application (2024-2029) & (MT)
Table 77. Global Finasteride Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Finasteride Product Portfolios and Specifications
Table 80. Merck Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Actavis Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 84. Actavis Finasteride Product Portfolios and Specifications
Table 85. Actavis Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 86. Actavis Main Business
Table 87. Actavis Latest Developments
Table 88. Sandoz Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 89. Sandoz Finasteride Product Portfolios and Specifications
Table 90. Sandoz Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 91. Sandoz Main Business
Table 92. Sandoz Latest Developments
Table 93. Teva Pharmaceuticals Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceuticals Finasteride Product Portfolios and Specifications
Table 95. Teva Pharmaceuticals Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 96. Teva Pharmaceuticals Main Business
Table 97. Teva Pharmaceuticals Latest Developments
Table 98. Cipla Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Finasteride Product Portfolios and Specifications
Table 100. Cipla Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 101. Cipla Main Business
Table 102. Cipla Latest Developments
Table 103. RelonChem Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 104. RelonChem Finasteride Product Portfolios and Specifications
Table 105. RelonChem Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 106. RelonChem Main Business
Table 107. RelonChem Latest Developments
Table 108. Dr. Reddy Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 109. Dr. Reddy Finasteride Product Portfolios and Specifications
Table 110. Dr. Reddy Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 111. Dr. Reddy Main Business
Table 112. Dr. Reddy Latest Developments
Table 113. Accord Pharmaceuticals Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 114. Accord Pharmaceuticals Finasteride Product Portfolios and Specifications
Table 115. Accord Pharmaceuticals Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 116. Accord Pharmaceuticals Main Business
Table 117. Accord Pharmaceuticals Latest Developments
Table 118. Henan Topfond Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 119. Henan Topfond Finasteride Product Portfolios and Specifications
Table 120. Henan Topfond Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 121. Henan Topfond Main Business
Table 122. Henan Topfond Latest Developments
Table 123. Zhejiang CONBA Pharmaceutical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhejiang CONBA Pharmaceutical Finasteride Product Portfolios and Specifications
Table 125. Zhejiang CONBA Pharmaceutical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 126. Zhejiang CONBA Pharmaceutical Main Business
Table 127. Zhejiang CONBA Pharmaceutical Latest Developments
Table 128. Shandong Renhetang Pharmaceutical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Renhetang Pharmaceutical Finasteride Product Portfolios and Specifications
Table 130. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 131. Shandong Renhetang Pharmaceutical Main Business
Table 132. Shandong Renhetang Pharmaceutical Latest Developments
Table 133. Guangdong Eashu Pharmacetical Basic Information, Finasteride Manufacturing Base, Sales Area and Its Competitors
Table 134. Guangdong Eashu Pharmacetical Finasteride Product Portfolios and Specifications
Table 135. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 136. Guangdong Eashu Pharmacetical Main Business
Table 137. Guangdong Eashu Pharmacetical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Finasteride
Figure 2. Finasteride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Finasteride Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Finasteride Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1mg Tablet
Figure 10. Product Picture of 5mg Tablet
Figure 11. Global Finasteride Sales Market Share by Type in 2022
Figure 12. Global Finasteride Revenue Market Share by Type (2018-2023)
Figure 13. Finasteride Consumed in Medical Uses
Figure 14. Global Finasteride Market: Medical Uses (2018-2023) & (MT)
Figure 15. Finasteride Consumed in Application 2
Figure 16. Global Finasteride Market: Application 2 (2018-2023) & (MT)
Figure 17. Global Finasteride Sales Market Share by Application (2022)
Figure 18. Global Finasteride Revenue Market Share by Application in 2022
Figure 19. Finasteride Sales Market by Company in 2022 (MT)
Figure 20. Global Finasteride Sales Market Share by Company in 2022
Figure 21. Finasteride Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Finasteride Revenue Market Share by Company in 2022
Figure 23. Global Finasteride Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Finasteride Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Finasteride Sales 2018-2023 (MT)
Figure 26. Americas Finasteride Revenue 2018-2023 ($ Millions)
Figure 27. APAC Finasteride Sales 2018-2023 (MT)
Figure 28. APAC Finasteride Revenue 2018-2023 ($ Millions)
Figure 29. Europe Finasteride Sales 2018-2023 (MT)
Figure 30. Europe Finasteride Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Finasteride Sales 2018-2023 (MT)
Figure 32. Middle East & Africa Finasteride Revenue 2018-2023 ($ Millions)
Figure 33. Americas Finasteride Sales Market Share by Country in 2022
Figure 34. Americas Finasteride Revenue Market Share by Country in 2022
Figure 35. Americas Finasteride Sales Market Share by Type (2018-2023)
Figure 36. Americas Finasteride Sales Market Share by Application (2018-2023)
Figure 37. United States Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Finasteride Sales Market Share by Region in 2022
Figure 42. APAC Finasteride Revenue Market Share by Regions in 2022
Figure 43. APAC Finasteride Sales Market Share by Type (2018-2023)
Figure 44. APAC Finasteride Sales Market Share by Application (2018-2023)
Figure 45. China Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Finasteride Sales Market Share by Country in 2022
Figure 53. Europe Finasteride Revenue Market Share by Country in 2022
Figure 54. Europe Finasteride Sales Market Share by Type (2018-2023)
Figure 55. Europe Finasteride Sales Market Share by Application (2018-2023)
Figure 56. Germany Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Finasteride Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Finasteride Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Finasteride Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Finasteride Sales Market Share by Application (2018-2023)
Figure 65. Egypt Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Finasteride in 2022
Figure 71. Manufacturing Process Analysis of Finasteride
Figure 72. Industry Chain Structure of Finasteride
Figure 73. Channels of Distribution
Figure 74. Global Finasteride Sales Market Forecast by Region (2024-2029)
Figure 75. Global Finasteride Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Finasteride Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Finasteride Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Finasteride Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Finasteride Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Finasteride
Figure 2. Finasteride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Finasteride Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Finasteride Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1mg Tablet
Figure 10. Product Picture of 5mg Tablet
Figure 11. Global Finasteride Sales Market Share by Type in 2022
Figure 12. Global Finasteride Revenue Market Share by Type (2018-2023)
Figure 13. Finasteride Consumed in Medical Uses
Figure 14. Global Finasteride Market: Medical Uses (2018-2023) & (MT)
Figure 15. Finasteride Consumed in Application 2
Figure 16. Global Finasteride Market: Application 2 (2018-2023) & (MT)
Figure 17. Global Finasteride Sales Market Share by Application (2022)
Figure 18. Global Finasteride Revenue Market Share by Application in 2022
Figure 19. Finasteride Sales Market by Company in 2022 (MT)
Figure 20. Global Finasteride Sales Market Share by Company in 2022
Figure 21. Finasteride Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Finasteride Revenue Market Share by Company in 2022
Figure 23. Global Finasteride Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Finasteride Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Finasteride Sales 2018-2023 (MT)
Figure 26. Americas Finasteride Revenue 2018-2023 ($ Millions)
Figure 27. APAC Finasteride Sales 2018-2023 (MT)
Figure 28. APAC Finasteride Revenue 2018-2023 ($ Millions)
Figure 29. Europe Finasteride Sales 2018-2023 (MT)
Figure 30. Europe Finasteride Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Finasteride Sales 2018-2023 (MT)
Figure 32. Middle East & Africa Finasteride Revenue 2018-2023 ($ Millions)
Figure 33. Americas Finasteride Sales Market Share by Country in 2022
Figure 34. Americas Finasteride Revenue Market Share by Country in 2022
Figure 35. Americas Finasteride Sales Market Share by Type (2018-2023)
Figure 36. Americas Finasteride Sales Market Share by Application (2018-2023)
Figure 37. United States Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Finasteride Sales Market Share by Region in 2022
Figure 42. APAC Finasteride Revenue Market Share by Regions in 2022
Figure 43. APAC Finasteride Sales Market Share by Type (2018-2023)
Figure 44. APAC Finasteride Sales Market Share by Application (2018-2023)
Figure 45. China Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Finasteride Sales Market Share by Country in 2022
Figure 53. Europe Finasteride Revenue Market Share by Country in 2022
Figure 54. Europe Finasteride Sales Market Share by Type (2018-2023)
Figure 55. Europe Finasteride Sales Market Share by Application (2018-2023)
Figure 56. Germany Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Finasteride Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Finasteride Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Finasteride Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Finasteride Sales Market Share by Application (2018-2023)
Figure 65. Egypt Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Finasteride Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Finasteride in 2022
Figure 71. Manufacturing Process Analysis of Finasteride
Figure 72. Industry Chain Structure of Finasteride
Figure 73. Channels of Distribution
Figure 74. Global Finasteride Sales Market Forecast by Region (2024-2029)
Figure 75. Global Finasteride Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Finasteride Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Finasteride Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Finasteride Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Finasteride Revenue Market Share Forecast by Application (2024-2029)
